Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Chereau

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Structural Biology|May 11, 2006
Understanding the role of the G-actin-binding domain of Ena/VASP in actin assemblyDavid Chereau, Roberto Dominguez
Biochemistry|March 30, 2005
A nucleotide binding site in caspase-9 regulates apoptosome activationDavid Chereau, Hua Zou, Alfred P Spada, et al.
Journal of Molecular Biology|May 16, 2006
Cortactin binding to F-actin revealed by electron microscopy and 3D reconstructionKiran Pant, David Chereau, Victoria Hatch, et al.
Cell Motility and the Cytoskeleton|December 18, 2008
The actin-binding domain of cortactin is dynamic and unstructured and affects lateral and longitudinal contacts in F-actinAlexander Shvetsov, Emir Berkane, David Chereau, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2005
Actin-bound structures of Wiskott-Aldrich syndrome protein (WASP)-homology domain 2 and the implications for filament assemblyDavid Chereau, Frederic Kerff, Philip Graceffa, et al.
Structure (London, England : 1993)|February 13, 2007
Structural basis for the actin-binding function of missing-in-metastasisSung Haeng Lee, Frederic Kerff, David Chereau, et al.
Science (New York, N.Y.)|April 12, 2008
Leiomodin is an actin filament nucleator in muscle cellsDavid Chereau, Malgorzata Boczkowska, Aneta Skwarek-Maruszewska, et al.
Journal of Molecular Biology|June 22, 2011
Conserved C-terminal charge exerts a profound influence on the aggregation rate of α-synucleinKaterina Levitan, David Chereau, Samuel I A Cohen, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2011
Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacementR Jeffrey Neitz, Andrei W Konradi, Hing L Sham, et al.
The Journal of Biological Chemistry|November 14, 2008
Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous systemKelly J Inglis, David Chereau, Elizabeth F Brigham, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Structural Biology|May 11, 2006
Understanding the role of the G-actin-binding domain of Ena/VASP in actin assemblyDavid Chereau, Roberto Dominguez
Biochemistry|March 30, 2005
A nucleotide binding site in caspase-9 regulates apoptosome activationDavid Chereau, Hua Zou, Alfred P Spada, et al.
Journal of Molecular Biology|May 16, 2006
Cortactin binding to F-actin revealed by electron microscopy and 3D reconstructionKiran Pant, David Chereau, Victoria Hatch, et al.
Cell Motility and the Cytoskeleton|December 18, 2008
The actin-binding domain of cortactin is dynamic and unstructured and affects lateral and longitudinal contacts in F-actinAlexander Shvetsov, Emir Berkane, David Chereau, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2005
Actin-bound structures of Wiskott-Aldrich syndrome protein (WASP)-homology domain 2 and the implications for filament assemblyDavid Chereau, Frederic Kerff, Philip Graceffa, et al.
Structure (London, England : 1993)|February 13, 2007
Structural basis for the actin-binding function of missing-in-metastasisSung Haeng Lee, Frederic Kerff, David Chereau, et al.
Science (New York, N.Y.)|April 12, 2008
Leiomodin is an actin filament nucleator in muscle cellsDavid Chereau, Malgorzata Boczkowska, Aneta Skwarek-Maruszewska, et al.
Journal of Molecular Biology|June 22, 2011
Conserved C-terminal charge exerts a profound influence on the aggregation rate of α-synucleinKaterina Levitan, David Chereau, Samuel I A Cohen, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2011
Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacementR Jeffrey Neitz, Andrei W Konradi, Hing L Sham, et al.
The Journal of Biological Chemistry|November 14, 2008
Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous systemKelly J Inglis, David Chereau, Elizabeth F Brigham, et al.
Pageof 2